This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. Researchers have applied ...

Explore how AI transforms cancer drug discovery by predicting proteins and accelerating drug candidate identification and ...

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced an expansion of their partnership with Pfizer. The parties will launch a new ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

At both Biotech Showcase and RESI JPM, BullFrog AI will highlight its proprietary BullFrog Data Networks ®, a data insights tool powered by the bfLEAP™ platform. BullFrog Data Networks ® evaluate high ...

Quantum computing and biotech companies are testing whether next-generation computing technology could help them develop ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Research Institute today announced they have entered into an agreement with Janssen Research & Development, LLC, a Johnson & ...